摘要
综合文献对肝细胞癌的诊治进展进行综述,介绍肝细胞癌的危险因素、预防、诊断及各种治疗方法,并对肝细胞癌的早期诊断以及采取更有效的治疗进行展望。
summary of an AASLD Single Topic Conference[J].Hepatology,2003,37(5):1202-1019.[8] Larsson SC,Wolk A.Coffee consumption and risk of liver cancer:a meta-analysis[J].Gastroenterology,2007,132(5):1740-1745.[9] Huxley R,Lee CM,Barzi F,et al.Coffee,decaffeinated coffee,and tea consumption in relation to incident type 2 diabetes mellitus:a systematic review with meta-analysis[J].Arch Intern Med,2009,169(22):20532063.[10] Liaw YF,Sung JJ,Chow WC,et al.Lamivudine for patients with chronic hepatitis B and advanced liver disease[J].N Engl J Med,2004,351(15):1521-1531.[11] Sung JJ,Tsoi KK,Wong VW,et al.Meta-analysis:Treatment of hepatitis B infection reduces risk of hepatocellular carcinom a [J].Aliment Pharmacol Ther,2008,28(9):1067-1077.[12] Singal AG,Volk ML,Jensen D,et al.A sustainedviral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus[J].Clin Gastroenterol Hepatol,2010,8(3):280288.[13] Di Bisceglie AM,Shiffman ML,Everson GT,et al.Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon[J].N Engl J Med,2008,359(23):2429-2441.[14] Bruix J,Sherman M.Management of hepatocellular carcinoma[J].Hepatology,2005,42(5):1208-1236.[15] Zhang BH,Yang BH,Tang ZY.Randomized controlled trial of screening for hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2004,130(7):417-422.[16] Singal A,Volk ML,Waljee A,et al.Meta-analysis:surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis[J].Aliment Pharmacol Ther,2009,30(1):37-47.[17] El-Serag HB,Marrero JA,Rudolph L,et al.Diagnosis and treatment of hepatocellular carcinoma[J].Gastroenterology,2008,134(6):1752-1763.[18] Llovet JM,Schwartz M,Mazzaferro V.Resection and liver transplantation for hepatocellular carcinoma[J].Semin Liver Dis,2005,25(2):181200.[19] Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [J].N Engl J Med,1996,334(11):693-699.[20] Pelletier SJ,Fu S,Thyagarajan V,et al.An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using Organ Procurement Transplant Network data[J].Liver Transpl,2009,15(8):859868.[21] Cho YK,Kim JK,Kim MY,et al.Systematic review of randomizedtrials for hepatocellular carcinoma treated with percutaneous ablation therapies[J].Hepatology,2009,49(2):453-459.[22] Bruix J,Sala M,Llovet JM.Chemoembolization for hepatocellular carcinoma[J].Gastroenterology,2004,127(5):179-188.[23] Salem R,Lewandowski RJ,Mulcahy MF,et al.Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres:a comprehensive report of longterm outcomes[J].Gastroenterology,2010,138(1):52-64.[24] Llovet JM,Ricci S,Mazzaferro V,et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med,2008,359(4):378-390.
出处
《中国当代医药》
2012年第20期16-18,共3页
China Modern Medicine
